$ZSBearishMed

This Growth Stock Is Down Over 40% in 2026. Will Investors Regret Not Buying the Dip?

Zscaler reported fiscal 2026 Q3 results (ended Apr. 30) after market close May 26; shares fell 31% the next day. The company said two senior sales employees left and issued conservative fiscal 2027 guidance, with ARR growth projected to slow to 16%. Fiscal 2026 Q3 ARR was $3.5B, up 25% year over year.

9/10
6/10
Med
Bearish
After-hours/next-day reaction to fiscal 2026 Q3 results and fiscal 2027 guidance (May 26 report; next-day plunge).
Risk-off: market is discounting guidance risk from sales disruption even as ARR growth remains strong.

Forward ARR growth guidance reset expectations despite solid reported ARR growth, driving a sharp selloff and increasing near-term execution risk.

Zscaler shares fell ~31% after reporting fiscal Q3 results and issuing conservative fiscal 2027 ARR guidance following two senior sales departures.

Bearish near-term bias until management clarifies sales-team disruption and ARR re-accelerates; potential mean-reversion if guidance proves conservative.

Background

The piece frames Zscaler’s zero-trust platform expansion (branches and AI-agent access controls) alongside a post-earnings guidance reset.

Why it matters

Despite 25% ARR growth in fiscal 2026 Q3, the company guided to slower fiscal 2027 ARR growth (to ~16%), which the market treated as a meaningful deterioration tied to sales leadership turnover.

Market relevance

Material for trading because the guidance cut following sales departures is the catalyst behind the immediate repricing, not the headline revenue growth.

Market effects

Highlights how cybersecurity growth stocks can re-rate on guidance sensitivity to go-to-market execution, even when ARR growth is intact.

No specific regional impact described beyond US-listed sentiment.

Zero-trust demand narrative remains intact, but execution/guidance risk can dominate valuation globally.

Alternative perspectives

If the conservative fiscal 2027 ARR growth outlook reflects temporary sales disruption, Zscaler’s strong customer momentum could lead to guidance beat and valuation rebound.

The article provides limited detail on the departures; traders may need to watch subsequent commentary on pipeline conversion, churn, and whether “Zero Trust Everywhere” customer growth translates into sustained ARR acceleration.

Key entities

  • Zscaler

    Cybersecurity firm whose fiscal Q3 results and conservative fiscal 2027 ARR guidance triggered a sharp selloff.

  • Kevin Rubin

    CFO cited as acknowledging near-term sales-team disruption during the guidance update.

Related articles

$ZSLow

A Post-Earnings Sell-Off Could Be an Incredible Buying Opportunity for This Stock

Zscaler (NASDAQ: ZS) shares fell 32% after its third-quarter earnings report as management guided 2027 annualized recurring revenue (ARR) growth of 16%–17%, down from 21% last quarter. The report attributed part of the slowdown to how Red Canary renewals are accounted for. Zscaler said usage-based pricing from AI-driven traffic accounted for over 30% of new annualized contract value in Q3.

$DDOGMedAI 8/10

Stocks Retreat as US-Iran Peace Hopes in Doubt

US stocks retreated as markets scaled back hopes for US-Iran peace. US MBA mortgage applications fell 2.5% (purchase -2.9%, refi -2.3%); the 30-year fixed rate dropped 8 bp to 6.57%. The Fed Beige Book was hawkish, citing slight-to-moderate growth and higher inflation; John Williams said no rate change is needed. Traders priced a 3% chance of a 25 bp hike.

$ONMedAI 8/10

Stocks Push Higher on US Labor Market Strength and AI Spending

US stocks rose as investors weighed strong labor-market data and ongoing AI spending, despite hawkish remarks from Cleveland Fed President Beth Hammack that the policy rate “may not be restrictive” and could need tightening if inflation stays elevated. Markets priced only a ~1% chance of a +25 bp Fed hike at June 16-17. Q1: 84% of 485 S&P 500 firms beat estimates; earnings seen +12% y/y.

$ZSLow

Why Is Zscaler (ZS) Stock Soaring Today

Zscaler (ZS) shares were trading at $153.68, down 30.3% year to date and 54.3% below its 52-week high of $336.27 (Nov. 2025), according to the article. It also says a $1,000 investment in Zscaler five years ago would now be worth $801.40, highlighting the stock’s longer-term underperformance.

$DELLMedAI 8/10

Microsoft initiated, Dell upgraded: Wall Street's top analyst calls

Morgan Stanley upgraded Dell to Equal Weight from Underweight and set a $448 target (from $170), citing Dell’s Q1 results and a Taiwan visit as signs it’s managing the semiconductor supply shortage better than peers. Other moves: Guggenheim raised Zscaler to Buy ($214); Citi to Buy Kohl’s ($22); Wells Fargo to Overweight Tandem Diabetes ($27); Truist to Outperform Federal Realty ($130). Truist cut Accenture to Hold ($210); Stephens cut Campbell’s to Equal Weight ($21). Texas Capital cut Caesars